Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial
Media-OutReach Newswire China Mobile Hong Kong to Launch its State-of-the-Art 5G Network Services with Leading Technology Starting Midnight on the First of April